Leonardo Mendes Bella

Leonardo Mendes Bella

Auto-generated profile, based on publicly available information

Leonardo Mendes Bella

Anhembi Morumbi University

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 August 2017 in Cellular Physiology and Biochemistry
Verified
Journal Article
Open access
FTFernando H. G. Tessaro
Fernando H. G. Tessaro
TAThais S. Ayala
Thais S. Ayala
ENEduardo L. Nolasco
Eduardo L. Nolasco
LBLeonardo M. Bella
Leonardo M. Bella
JMJoilson O. Martins
Joilson O. Martins
Background/Aims: Diabetic subjects are more susceptible to infections, which is partially due to insulin deficiency and hyperglycemia. We hypothesized that insulin influences cytokine release by macrophages from diabetic C57BL/6 mice stimulated with lipopolysaccharides (LPS). Methods: Bone marrow-derived macrophages (BMDM) and tissue-specific macrophages from diabetic (alloxan 60 mg/kg, i.v.) male C57BL/6 mice were stimulated by LPS (100 ng/mL) and/or treated by insulin (1 mU/mL). Results: Using BMDM from diabetic mice, we showed that LPS induced an increase in TNF-α and IL-6 release and p38, SAPK/JNK, ERK 1/2, and Akt (308-Thr and 473-Ser) phosphorylation but not in PKCα/β II and delta. Insulin increased TNF-α and IL-6 secretion in LPS-stimulated macrophages as well as p-p38, p-SAPK/JNK, p-ERK 1/2, p-PI3K (p55) and p-Akt (473-Ser) expression. Furthermore, PI3-kinase inhibition by wortmannin decreased TNF-α release, and inhibition by LY294002 decreased both TNF-α and IL-6 levels after LPS-insulin treatment. PD98059, which inhibits the ERK upstream activators MAPK kinase (MKK) 1 and MKK2, reduced the effect promoted by insulin in BMDM stimulated by LPS In tissue-specific macrophages, insulin reduced LPS-induced TNF-α, IL-6 and IL-1β secretion in alveolar and peritoneal macrophages. Conclusion: These data suggest that insulin through the modulation of PI3-kinase and ERK 1/2 pathways drive different responses in macrophages, thereby enhancing our understanding of the plasticity of these cells.

7 August 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TAThais Soprani Ayala
Thais Soprani Ayala
FTFernando Henrique Galvão Tessaro
Fernando Henrique Galvão Tessaro
GJGrasielle Pereira Jannuzzi
Grasielle Pereira Jannuzzi
LBLeonardo Mendes Bella
Leonardo Mendes Bella
KFKaren Spadari Ferreira
Karen Spadari Ferreira
JMJoilson O. Martins
Joilson O. Martins
Macrophages may be a crucial aspect of diabetic complications associated with the inflammatory response. In this study, we examined how hyperglycaemia, a common aspect of diabetes, modulates bone marrow-derived macrophages (BMDMs) under an inflammatory stimulus. To perform this study, BMDMs from non-diabetic and diabetic (60 mg/kg alloxan, i.v.) male C57BL/6 mice (CEUA/FCF/USP-488) were cultured under normal (5.5 mM) and high glucose (HG, 25 or 40 mM) conditions and stimulated or not stimulated with lipopolysaccharide (LPS, 100 ng/mL). Compared to the BMDMs from the normoglycaemic mice, the LPS-stimulated BMDMs from the diabetic mice presented reduced TLR4 expression on the cell surface, lower phagocytic capacity, and reduced secretion of NO and lactate but greater oxygen consumption and greater phosphorylation of p46 SAPK/JNK, p42 ERK MAPK, pAKT and pPKC-δ. When the BMDMs from the non-diabetic mice were cultured under high-glucose conditions and stimulated with LPS, TLR4 expression was reduced on the cell surface and NO and H2O2levels were reduced. In contrast, the diabetic BMDMs cultured under high glucose conditions presented increased levels of lactate and reduced phosphorylation of AKT, PKC-δ and p46 SAPK/JNK but enhanced phosphorylation of the p46 subunit of SAPK/JNK after LPS stimulation. High glucose levels appear to modify macrophage behaviour, affecting different aspects of diabetic and healthy BMDMs under the same LPS stimulus. Thus, hyperglycaemia leaves a glucose legacy, altering the basal steady state of macrophages.

1 March 2020 in Immunobiology
Verified
Journal Article
Open access
FTFernando Henrique Galvão Tessaro
Fernando Henrique Galvão Tessaro
TAThais Soprani Ayala
Thais Soprani Ayala
LBLeonardo Mendes Bella
Leonardo Mendes Bella
JMJoilson O. Martins
Joilson O. Martins
Diabetes causes dysregulation in signal transduction in immune cells leading to an impaired response to pathogens. Herein, we investigated the impact of type 1 diabetes (T1D) in bone marrow-derived macrophages (BMDM), using male non-diabetic and diabetic C57BL/6 mice (alloxan 60 mg/kg, i.v., CEUA/FCF/USP - 467). Diabetic BMDM expressed impaired phosphoinositide 3-kinase (PI3K), being lower p-PI3K p55 levels and higher levels of PI3K p110 alpha, whereas protein kinase B (PKB/Akt) (Ser-473 and Thr-308), extracellular signal-regulated kinases (ERK 1/2), and stress-activated protein kinase (SAPK/JNK) were enhanced compared to non-diabetic BMDM. Further evaluation of the responsiveness to lipopolysaccharide (LPS; 0.1 and 1 ug/mL), diabetic BMDM and peritoneal macrophage secreted dysregulated levels of tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-10 levels. In 24 h, diabetic BMDM stimulated by LPS presented lower metabolic activity, with no differences in cell surveillance. Therefore, LPS re-stimulation (0.1 ug/mL) in diabetic BMDM resulted in higher secretion of TNF-α compared to non-diabetic BMDM. However, diabetic peritoneal macrophages secreted similar IL-6 levels in the first and additional 24 h of LPS stimulation. In general, our results demonstrated that diabetes exerts an impact in both BMDM and peritoneal macrophages ability to secrete cytokine under LPS stimulation.

1 January 2017 in BioMed Research International
Verified
Journal Article
Open access
PDF file
LBLeonardo M. Bella
Leonardo M. Bella
IFIsis Fieri
Isis Fieri
FTFernando H. G. Tessaro
Fernando H. G. Tessaro
ENEduardo L. Nolasco
Eduardo L. Nolasco
FNFernanda P. B. Nunes
Fernanda P. B. Nunes
JMJoilson O. Martins
Joilson O. Martins
Background/Aims. The effects of cholecalciferol supplementation on the course of diabetes in humans and animals need to be better understood. Therefore, this study investigated the effect of short-term cholecalciferol supplementation on biochemical and hematological parameters in mice.Methods. Male diabetic (alloxan, 60 mg/kg i.v., 10 days) and nondiabetic mice were supplemented with cholecalciferol for seven days. The following parameters were determined: serum levels of 25-hydroxyvitamin D, phosphorus, calcium, urea, creatinine, alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, red blood cell count, white blood cell count (WBC), hematocrit, hemoglobin, differential cell counts of peritoneal lavage (PeL), and bronchoalveolar lavage (BAL) fluids and morphological analysis of lung, kidney, and liver tissues.Results. Relative to controls, cholecalciferol supplementation increased serum levels of 25-hydroxyvitamin D, calcium, hemoglobin, hematocrit, and red blood cell counts and decreased leukocyte cell counts of PeL and BAL fluids in diabetic mice. Diabetic mice that were not treated with cholecalciferol had lower serum calcium and albumin levels and hemoglobin, WBC, and mononuclear blood cell counts and higher serum creatinine and urea levels than controls.Conclusion. Our results suggest that cholecalciferol supplementation improves the hematological parameters and reduces leukocyte migration into the PeL and BAL lavage of diabetic mice.

14 March 2021 in Amino Acids
Verified
Journal Article
Closed access
PDF file
ABAndrea Bonvini
Andrea Bonvini
MRMarcelo Macedo Rogero
Marcelo Macedo Rogero
ACAudrey Coqueiro
Audrey Coqueiro
RRRaquel Raizel
Raquel Raizel
LBLeonardo Mendes Bella
Leonardo Mendes Bella
JTJulio Tirapegui
Julio Tirapegui

6 June 2024 in Revista Fitos
Verified
Journal Article
Open access
Carlos Rocha OliveiraCarlos Rocha Oliveira
Carlos Rocha Oliveira
LBLeonardo Mendes Bella
Leonardo Mendes Bella
Rodolfo P VieiraRodolfo P Vieira
Rodolfo P Vieira
MDMarília Cristina Duarte
Marília Cristina Duarte
The aim of the study was to evaluate the effects of essential oil from Cymbopogon martinii (CMEO) on lipopolysaccharide (LPS)-stimulated human fibroblast cells. The fibroblasts were cultured using Iscove's medium and stimulated by LPS (1μg/mL). The cytotoxicity of CMEO was evaluated by MTT and collagen concentration by Sirius red. Collagenase activity, hyaluronic acid, and the concentrations of IL-1β; IL-6; MCP-1, and MIP-1-α were evaluated by ELISA. The effect of CMEO on the mRNA levels and the secretion of MMP-1; MMP-2; and MMP-9 enzymes in fibroblasts were evaluated by RT-qPCR and ELISA, respectively. CMEO was cytotoxic against fibroblasts, in which 10μg/mL inhibited 50% of cell viability. When treated with CMEO, the fibroblasts produced more collagen and hyaluronic acid compared to control cells. When stimulated by LPS, fibroblasts exhibited higher production of IL-6, IL-1β, MCP-1, and MIP-1α compared to control cells. However, the treatment of fibroblasts with CMEO reduces cytokines secretion and enzyme expression. In summary, CMEO reduced the secretion of cytokines and metalloproteinases, in addition to increasing the synthesis of extracellular matrix elements. The study demonstrated the effects of CMEO on the modulation of inflammatory mediators and decreasing the mRNA and secretion levels of metalloproteinases.